Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Change in Cash (2023 - 2025)

Historic Change in Cash for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$149.1 million.

  • Nuvation Bio's Change in Cash fell 340842.55% to -$149.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $68.9 million, marking a year-over-year increase of 112072.33%. This contributed to the annual value of -$6.9 million for FY2024, which is 8815.06% up from last year.
  • Per Nuvation Bio's latest filing, its Change in Cash stood at -$149.1 million for Q3 2025, which was down 340842.55% from $200.0 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Change in Cash ranged from a high of $200.0 million in Q2 2025 and a low of -$149.1 million during Q3 2025
  • Its 3-year average for Change in Cash is -$200181.8, with a median of -$225000.0 in 2024.
  • Examining YoY changes over the last 5 years, Nuvation Bio's Change in Cash showed a top increase of 8898577.78% in 2025 and a maximum decrease of 340842.55% in 2025.
  • Over the past 3 years, Nuvation Bio's Change in Cash (Quarter) stood at $18.3 million in 2023, then crashed by 68.85% to $5.7 million in 2024, then tumbled by 2721.29% to -$149.1 million in 2025.
  • Its Change in Cash was -$149.1 million in Q3 2025, compared to $200.0 million in Q2 2025 and $12.3 million in Q1 2025.